An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)-Reference-Cited by-同舟云学术

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)

Published:2018-08-03 Issue:5 Volume:58 Page:2145-2156
ISSN:1436-6207
Container-title:European Journal of Nutrition
language:en
Short-container-title:Eur J Nutr

Author:

Simeoni Mariadelina,Citraro Maria Lucia,Cerantonio Annamaria,Deodato Francesca,Provenzano Michele,Cianfrone Paola,Capria Maria,Corrado Silvia,Libri Emanuela,Comi Alessandro,Pujia Arturo,Abenavoli Ludovico,Andreucci Michele,Cocchi Massimo,Montalcini Tiziana,Fuiano Giorgio

Funder

Bromatech Ltd

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/article/10.1007/s00394-018-1785-z/fulltext.html

Reference62 articles.

1. Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823–1836. https://doi.org/10.1042/BCJ20160510

2. Rodríguez JM, Murphy K, Stanton C et al (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26:26050. https://doi.org/10.3402/mehd.v26.26050

3. Claesson MJ, Jeffery IB, Conde S et al (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488:178–184. https://doi.org/10.1038/nature11319